Ознакомительная версия. Доступно 26 страниц из 126
Phipps, William Thomas, Kathryn H. Schmitz, and Mindy S. Kurzer. “The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women.” Cancer Epidemiology and Prevention Biomarkers 22, no. 5 (2013): 756–764.
82. Petersen, Anne Marie W., and Bente Klarlund Pedersen. “The anti-inflammatory effect of exercise.” Journal of Applied Physiology 98, no. 4 (2005): 1154–1162; Jelleyman, Charlotte, Thomas Yates, Gary O’Donovan, Laura J. Gray, James A. King, Kamlesh Khunti, and Melanie J. Davies. “The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis.” Obesity Reviews 16, no. 11 (2015): 942–961; Almenning, Ida, Astrid Rieber-Mohn, Kari Margrethe Lundgren, Tone Shetelig Løvvik, Kirsti Krohn Garnæs, and Trine Moholdt. “Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: a pilot study.” PLOS One 10, no. 9 (2015): e0138793.
83. Warren, Michelle P., and Abigail T. Chua. “Exercise-induced amenorrhea and bone health in the adolescent athlete.” Annals of the New York Academy of Sciences 1135, no. 1 (2008): 244–252; Sokoloff, Natalia Cano, Madhusmita Misra, and Kathryn E. Ackerman. (2016). “Exercise, training, and the hypothalamic-pituitary-gonadal axis in men and women.” Sports Endocrinology, vol. 47. Basel: Karger Publishers, 27–43; Wu, T., X. Gao, M. Chen, and R.M. Van Dam. “Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis.” Obesity Reviews 10, no. 3 (2009): 313–323.
84. Trapp, E. Gail, Donald J. Chisholm, Judith Freund, and Stephen H. Boutcher. “The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women.” International Journal of Obesity 32, no. 4 (2008): 684.
85. Brand, Serge, Edith Holsboer-Trachsler, José Raúl Naranjo, and Stefan Schmidt. “Influence of mindfulness practice on cortisol and sleep in long-term and short-term meditators.” Neuropsychobiology 65, no. 3 (2012): 109–118.
86. Там же; Tang, Yi-Yuan, Britta K. Hölzel, and Michael I. Posner. “The neuroscience of mindfulness meditation.” Nature Reviews Neuroscience 16, no. 4 (2015): 213–225; Gotink, Rinske A., Rozanna Meijboom, Meike W. Vernooij, Marion Smits, and MG Myriam Hunink. “8-week mindfulness based stress reduction induces brain changes similar to traditional long-term meditation practice – a systematic review.” Brain and Cognition 108 (2016): 32–41.
87. Peterson, Linda Gay, and Lori Pbert. “Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders.” American Journal of Psychiatry 149, no. 7 (1992): 936–943; Goyal, Madhav, Sonal Singh, Erica MS Sibinga, Neda F. Gould, Anastasia Rowland-Seymour, Ritu Sharma, Zackary Berger et al. “Meditation programs for psychological stress and well-being: a systematic review and meta-analysis.” JAMA Internal Medicine 174, no. 3 (2014): 357–368; Kabat-Zinn, Jon, Elizabeth Wheeler, Timothy Light, Anne Skillings, Mark J. Scharf, Thomas G. Cropley, David Hosmer, and Jeffrey D. Bernhard. “Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing photo therapy (UVB) and photochemotherapy (PUVA).” Psychosomatic Medicine 60, no. 5 (1998): 625–632.
88. Kaplan, Stephen. (1992). “The restorative environment: Nature and human experience.” Role of Horticulture in Human Well-Being and Social Development: A National Symposium. Arlington, Virginia: Timber Press, 134–142; Bowler, Diana E., Lisette M. Buyung-Ali, Teri M. Knight, and Andrew S. Pullin. “A systematic review of evidence for the added benefits to health of exposure to natural environments.” BMC Public Health 10, no. 1 (2010): 456; Shanahan, Danielle F., Robert Bush, Kevin J. Gaston, Brenda B. Lin, Julie Dean, Elizabeth Barber, and Richard A. Fuller. “Health benefits from nature experiences depend on dose.” Scientific Reports 6, no. 28551 (2016): 1–10.
89. Ulrich, Roger S., Robert F. Simons, Barbara D. Losito, Evelyn Fiorito, Mark A. Miles, and Michael Zelson. “Stress recovery during exposure to natural and urban environments.” Journal of Environmental Psychology 11, no. 3 (1991): 201–230.
Глава 14
1. Iacovides, Stella, Ingrid Avidon, and Fiona C. Baker. “What we know about primary dysmenorrhea today: a critical review.” Human Reproduction Update 21, no. 6 (2015): 762–778.
2. Ju, Hong, Mark Jones, and Gita Mishra. “The prevalence and risk factors of dysmenorrhea.” Epidemiologic Reviews (2013): 104–113.
3. Lefebvre, Guylaine, Odette Pinsonneault, Viola Antao, Amanda Black, Margaret Burnett, Kymm Feldman, Robert Lea, and Magali Robert. “Primary dysmenorrhea consensus guideline.” Journal of Obstetrics and Gynaecology Canada 27, no. 12 (2005): 1117–1146; Iacovides, Stella, Ingrid Avidon, and Fiona C. Baker. “What we know about primary dysmenorrhea today: a critical review.” Human Reproduction Update 21, no. 6 (2015): 763.
4. Iacovides, Stella, Ingrid Avidon, and Fiona C. Baker. “What we know about primary dysmenorrhea today: a critical review.” Human Reproduction Update 21, no. 6 (2015): 763; Ju, Hong, Mark Jones, and Gita Mishra. “The prevalence and risk factors of dysmenorrhea.” Epidemiologic Reviews (2013): 104.
5. Lefebvre, Guylaine, Odette Pinsonneault, Viola Antao, Amanda Black, Margaret Burnett, Kymm Feldman, Robert Lea, and Magali Robert. “Primary dysmenorrhea consensus guideline.” Journal of Obstetrics and Gynaecology Canada 27, no. 12 (2005): 1120.
6. Iacovides, Stella, Ingrid Avidon, and Fiona C. Baker. “What we know about primary dysmenorrhea today: a critical review.” Human Reproduction Update 21, no. 6 (2015): 763; Ju, Hong, Mark Jones, and Gita Mishra. “The prevalence and risk factors of dysmenorrhea.” Epidemiologic Reviews (2013): 104.
7. Iacovides, Stella, Ingrid Avidon, and Fiona C. Baker. “What we know about primary dysmenorrhea today: a critical review.” Human Reproduction Update 21, no. 6 (2015): 762–778.
8. Ricciotti, Emanuela, and Garret A. FitzGerald. “Prostaglandins and inflammation.” Arteriosclerosis, Thrombosis, and Vascular Biology 31, no. 5 (2011): 986–1000.
9. Jabbour, Henry N., Kurt J. Sales, Rob D. Catalano, and Jane E. Norman. “Inflammatory pathways in female reproductive health and disease.” Reproduction 138, no. 6 (2009): 909.
10. Там же, 903–919.
11. Там же, 986; You & Your Hormones | Hormones | Prostaglandins. “You & Your Hormones.” Accessed January 12, 2017. www.yourhormones.info/hormones/prostaglandins.aspx
12. Lundström, V., and K. Green. “Endogenous levels of prostaglandin F 2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women.” American Journal of Obstetrics and Gynecology 130, no. 6 (1978): 640–646.
13. “Nonsteroidal anti-inflammatory drug.” Accessed September 28, 2017. en.wikipedia.org/wiki/Nonsteroidal_anti– inflammatory_drug
14. Iacovides, Stella, Ingrid Avidon, and Fiona C. Baker. “What we know about primary dysmenorrhea today: a critical review.” Human Reproduction Update 21, no. 6 (2015): 762–778; Gislason, Gunnar H. “NSAIDs and cardiovascular
Ознакомительная версия. Доступно 26 страниц из 126
